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Mycobacterium tuberculosis
 
 (
 
M.tb
 
) survives in macrophages in part by limiting phagosome–
lysosome (P-L) fusion. 
 
M.tb
 
 mannose-capped lipoarabinomannan (ManLAM) blocks 
phagosome maturation. The pattern recognition mannose receptor (MR) binds to the 
ManLAM mannose caps and mediates phagocytosis of bacilli by human macrophages. Using 
quantitative electron and confocal microscopy, we report that engagement of the MR by 
ManLAM during the phagocytic process is a key step in limiting P-L fusion. P-L fusion of 
ManLAM microspheres was significantly reduced in human macrophages and an MR-
expressing cell line but not in monocytes that lack the receptor. Moreover, reversal of P-L 
fusion inhibition occurred with MR blockade. Inhibition of P-L fusion did not occur with 
entry via Fc
 
 
 
 receptors or dendritic cell–specific intracellular adhesion molecule 3 grabbing 
nonintegrin, or with phosphatidylinositol-capped lipoarabinomannan. The ManLAM 
mannose cap structures were necessary in limiting P-L fusion, and the intact molecule was 
required to maintain this phenotype. Finally, MR blockade during phagocytosis of virulent 
 
M.tb
 
 led to a reversal of P-L fusion inhibition in human macrophages (84.0 
 
 
 
 5.1% vs. 38.6 
 
 
 
 0.6%). Thus, engagement of the MR by ManLAM during the phagocytic process directs 
 
M.tb
 
 to its initial phagosomal niche, thereby enhancing survival in human macrophages.
 
Mycobacterium tuberculosis 
 
(
 
M.tb
 
) has developed
multiple strategies to enhance its entry and intra-
cellular survival in mononuclear phagocytes by
engaging a defined set of phagocytic receptors,
thereby initiating specific signaling pathways and
modulating several immunobiological processes
during and after phagocytosis (1). A prominent
mannose-containing lipoglycan of the 
 
M.tb
 
 cell
wall, the terminal mannose-capped lipoarabi-
nomannan (ManLAM) (2), has been directly
implicated in the regulation of several of these
processes (3). The presence of ManLAM on the
mycobacterial surface (4) places this molecule in
an ideal position to mediate the initial interac-
tions between 
 
M.tb
 
 and macrophages.
After phagocytosis, 
 
M.tb
 
 resides in a phago-
some that does not mature into a phagolysosome,
considered a critical aspect of disease pathogenesis
(5, 6). The biochemical mechanisms underlying
this phenomenon have begun to be elucidated
(7, 8). ManLAM has been shown to be a critical
regulator of phagosome maturation in murine
macrophages and a human monocytic cell line
(8, 9). ManLAM blocks the increase of macro-
phage cytosolic Ca
 
2
 
 
 
 and thereby inhibits in-
teraction of the phosphatidylinositol 3 kinase
(PI3K), hVPS34, with calmodulin, a step nec-
essary for the production of PI3-phosphate
involved in the recruitment of the Rab5 effector
early endosomal antigen 1 to phagosomes. Early
endosomal antigen 1 is necessary for the delivery
of lysosomal components from the trans-Golgi
network to the phagosome and regulates fusion
of phagosomes with vesicles of the endosomal–
lysosomal pathway (10).
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monocyte-derived macrophages; 
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P-L, phagosome–lysosome; 
PRR, pattern recognition 
receptor; TEM, transmission 
electron microscopy. 
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For professional phagocytes such as macrophages, the time
frame from the phagocytosis of a microbe to the maturation
of its phagosome is short (11). Thus it is critical to explore the
phagocytic process itself in initiating the development of the
unique phagosome of 
 
M.tb
 
. Macrophages have evolved a re-
stricted number of phagocytic receptors, termed pattern rec-
ognition receptors (PRRs), which recognize conserved mo-
tifs, commonly carbohydrates, on the surface of microbes
(12). Such receptors include the C-type lectins mannose re-
ceptor (MR) and DC-specific intracellular adhesion molecule
3 grabbing nonintegrin (DC-SIGN),
 
 
 
among others (13). Hu-
man macrophages primarily use the MR as well as comple-
ment receptor 3 for the phagocytosis of 
 
M.tb
 
 (14). These re-
ceptors are distinguished by the fact that they mediate the
engulfment of microbes without necessarily inciting a proin-
flammatory response (11) and thereby have long been postu-
lated to enhance early intracellular survival of the microbe.
We have previously determined that the terminal man-
nose caps of 
 
M.tb
 
 ManLAM engage the MR during the
phagocytic process by human macrophages (15). ManLAM
caps also bind to DC-SIGN on DCs (16, 17). In contrast, phos-
phatidyl-
 
myo
 
-inositol capped lipoarabinomannan (PILAM)
from avirulent 
 
Mycobacterium smegmatis
 
 does not engage the
MR (15) or DC-SIGN (16), but rather TLR2, thereby acti-
vating a proinflammatory response (18). Thus, the terminal
components of ManLAM are very important in host cell rec-
ognition and response. The fact that the MR-dependent
phagocytosis is associated with an anti-inflammatory program
and is not coupled with activation of the NADPH oxidase
(19, 20), together with evidence that ManLAM inhibits IL-
12 production via the MR by generating a negative signal in
the cell (21), provides support for the preferential use of the
MR-ManLAM pathway in macrophages by 
 
M.tb
 
.
Because the involvement of specific receptors has been
linked to phagosomal trafficking (22–25), we explored
whether following engagement of ManLAM the MR ini-
tiates a phagocytic process that results in a phagosome with
altered fusogenic properties. We report the first evidence that
MR-mediated phagocytosis by primary human macrophages
directs ManLAM and 
 
M.tb
 
 bacilli to a phagosomal compart-
ment that has limited fusion with lysosomes. We show that
the influence of the MR is specific and sufficient in its effect
and that its engagement by the terminal mannose caps of
ManLAM plays an important role in this process. These stud-
ies indicate that by regulating the earliest phagosomal traffic
following phagocytosis, the MR phagocytic pathway enables
ManLAM-containing 
 
M.tb
 
 to escape P-L fusion to establish
its residence in the cell.
 
RESULTS
ManLAM-mediated phagocytosis by human macrophages 
results in limited P-L fusion
 
To assess the role of ManLAM in regulating P-L fusion in
primary human macrophages, ManLAM (from the virulent
Figure 1. ManLAM bead phagosomes demonstrate limited fusion 
with lysosomes in macrophages after phagocytosis. Low-power electron 
micrographs of P-L fusion events using (A) washed beads ( 24,000), (B) HSA 
beads ( 14,000) and (C) ManLAM beads ( 12,000). Lysosomes contain 
black particulate material. High-power electron micrographs of (D) ManLAM 
bead phagosomes shown with a neighboring lysosome (L) that is not fused 
( 40,000), and of (E) washed beads fused with lysosomes forming a phagoly-
sosome ( 60,000). (F) Extent of P-L fusion of washed, HSA, and ManLAM 
bead phagosomes. MDMs in monolayer culture were pulsed/chased with 
1 mg/ml horseradish peroxidase for 2 h at 37 C. A synchronized phagocytosis 
assay was performed for the indicated times. After fixation, MDMs were 
processed for TEM. The percentage of P-L fusion (mean   SEM, n   2) was 
significantly reduced with ManLAM beads compared with both washed and 
HSA bead controls (P   0.005; one-way ANOVA). 
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M.tb
 
 strain Erdman) or control microspheres (beads) (washed
or sham-treated [i.e., human serum albumin (HSA)-coated])
were added to monocyte-derived macrophages (MDMs) in a
synchronized phagocytosis assay, and P-L fusion was assessed
via quantitative transmission electron microscopy (TEM) us-
ing peroxidase as a lysosomal marker. Fig. 1, A–E shows
photomicrographs of the TEM assay used showing the ap-
pearance of lysosomes and the P-L fusion patterns seen with
the different beads.
P-L fusion for washed and HSA beads was 67.9 
 
 
 
 3.0%
and 36.2 
 
 
 
 4.5%, respectively, after 60 min (Fig. 1 F). Thus,
HSA precoating had a reproducible effect on P-L fusion and
was an important control to include in our studies. In con-
trast to the control beads, P-L fusion for ManLAM beads
was significantly reduced to 7.0 
 
 
 
 1.3% (
 
n
 
 
 
 
 
 2, P 
 
 
 
 0.005
relative to both control groups) (Fig. 1 F). To further sup-
port our finding that phagosomes containing ManLAM
beads exhibit limited P-L fusion, we quantified the amount
of immunogold staining for the lysosome-associated mem-
brane glycoprotein (LAMP-1) in bead phagosomes using
TEM immunohistochemistry after synchronized phagocyto-
sis (Fig. 2, A–C). Control bead phagosomes stained intensely
for LAMP-1 (Fig. 2, A and B). In contrast, ManLAM bead
phagosomes exhibited considerably reduced LAMP-1 stain-
ing (Fig. 2 C). The quantification and distribution of
Figure 2. LAMP-1 staining on ManLAM bead phagosomes in 
macrophages is reduced. Electron micrographs ( 20,000) of (A) 
washed and (B) HSA bead phagosomes show higher levels of LAMP-1 
accumulation than (C) ManLAM bead phagosomes. (D) A synchronized 
phagocytosis assay was performed for 60 min. After fixation, MDMs 
were processed for immunohistochemical TEM. The distribution of 
LAMP-1 staining is shown as the percentage of LAMP-1–positive phago-
somes containing washed, HSA, or ManLAM beads (mean   SEM, n   2). 
(E) HSA bead phagosomes show a higher degree of LAMP-1 colocalization 
than ManLAM bead phagosomes in macrophages following phagocytosis. 
MDM monolayers were incubated with either HSA or ManLAM fluorescent 
beads for 2 h. After washing, monolayers were fixed, permeabilized, and 
incubated with mouse anti–human LAMP-1 mAb followed by goat anti–
mouse IgG secondary antibody. LAMP-1 colocalization was enumerated 
by confocal microscopy. Compartments that stain positive for LAMP-1 
are red, beads in unfused phagosomes are green, and beads in fused 
phagolysosomes are yellow. The photomicrographs are from one 
representative experiment (n   3).
Figure 3. ManLAM from M.tb strains but not PILAM from 
M. smegmatis limits P-L fusion in macrophages. Washed, PILAM-, 
Ra-ManLAM-, Rv-ManLAM-, and Erd-ManLAM-coated beads were incubated 
with MDMs for the indicated times in the synchronized phagocytosis 
assay. The extent of P-L fusion of bead phagosomes was examined and 
enumerated via TEM as described in Fig. 1 F (mean   SEM, n   2).
 
LAMP-1-positive phagosomes, indicative of P-L fusion
events, are shown in Fig. 2 D. Relative to control beads,
ManLAM bead phagosomes demonstrated a higher percent- 
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age of weak staining (low number of gold particles/phago-
some). As the number of gold particles/phagosome in-
creased, these relative percentages shifted such that with
strong staining (especially 
 
 
 
24 gold particles/phagosome),
there was a much higher percentage of control bead phago-
somes relative to ManLAM bead phagosomes.
We next used confocal microscopy to assess P-L fusion
as a complementary approach to the TEM studies. Green
fluorescent beads were coated with or without ManLAM
and added to MDM monolayers in the synchronized
phagocytosis assay. The cells were fixed, immunostained,
and analyzed for colocalization of bead phagosomes with
LAMP-1 (Fig. 2 E). Consistent with the TEM studies, P-L
fusion for washed and HSA beads was 61 
 
 
 
 6% and 39 
 
 
 
3%, respectively. In contrast, P-L fusion for ManLAM
beads was reduced to 19 
 
 
 
 3% (
 
n
 
 
 
 
 
 3, P 
 
 
 
 0.005 relative
to both control groups).
To compare the degree of P-L fusion by ManLAMs
from different 
 
M.tb
 
 strains, we used in the TEM assay beads
coated with ManLAMs from the 
 
M.tb
 
 virulent strains Erd-
man (Erd-ManLAM) and H
 
37
 
R
 
v
 
 (Rv-ManLAM), and the
attenuated strain H
 
37
 
R
 
a
 
 (Ra-ManLAM). As above, Erd-
ManLAM beads demonstrated limited P-L fusion (7.7 
 
 
 
1.2%) compared with the control beads (73.2 
 
 
 
 1.9%) at
120 min (Fig. 3). The reduction in P-L fusion was equiva-
lent for the Rv- and Ra-ManLAM beads (12.0 
 
 
 
 2.0% and
10.9 
 
 
 
 3.3%, respectively) at this time point. These results
demonstrate that ManLAM-mediated phagocytosis by hu-
man macrophages leads to limited P-L fusion.
 
The terminal mannose caps of ManLAM are important 
in limiting P-L fusion in human macrophages
 
We used PILAM from 
 
M. smegmatis
 
 to assess whether the
mannose capping found in ManLAM is important in limiting
P-L fusion. In contrast to the results with ManLAM, P-L fu-
sion for PILAM beads was comparable to that of control
beads (55.0 
 
 
 
 0.3%) after 120 min (Fig. 3). Thus the man-
nose caps of ManLAM appeared to be important in limiting
P-L fusion. This result provided the first clue for involve-
ment of the macrophage MR in this process. To further
identify the domains of ManLAM that are important in lim-
iting P-L fusion, we coated beads with deacylated ManLAM
(dManLAM), lipomannan (LM), arabinomannan, and man-
nan, as well as with intact ManLAM from 
 
M.tb
 
. P-L fusion
was assessed in the TEM assay for periods up to 120 min
(Fig. 4). Phagosomes containing LM-coated beads limited
fusion to a small extent, whereas phagosomes containing
mannan-, arabinomannan-, and dManLAM-coated beads
limited fusion with lysosomes to a similar degree as for Man-
LAM bead phagosomes up to 60 min (Fig. 4). Thus, the ter-
Figure 4. The terminal mannosyl caps of ManLAM are important 
in limiting P-L fusion. Beads coated with HSA, intact ManLAM or its 
substructures LM, mannan, arabinomannan, and dManLAM were used 
with MDMs in the synchronized phagocytosis assay for the indicated 
times. P-L fusion was examined and enumerated via TEM as in Fig. 1 F 
(mean   SEM, n   2). 
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minal mannose cap structures and branching arabinofurans
are important in limiting P-L fusion. Beads coated with in-
tact ManLAM continued to exhibit limited fusion at 120
min, whereas the inhibition of P-L fusion observed with the
subcomponents of ManLAM began to reverse over this pe-
riod (Fig. 4). This result suggests that both the fatty acids and
terminal mannose caps of ManLAM are important in main-
taining limited P-L fusion over time.
 
Limited P-L fusion is restricted to the ManLAM 
bead phagosome
 
In considering the potential mechanisms for the limited P-L
fusion observed with the ManLAM beads, we next exam-
ined whether phagocytosis of these beads resulted in a global
decrease in P-L fusion events in the macrophage. We used
serum-opsonized zymosan as a phagocytic particle that is in-
gested via complement receptors and Fc
 
 
 
 receptors and un-
dergoes P-L fusion (26). We incubated MDMs with Man-
LAM beads and opsonized zymosan particles individually or
in combination and assessed P-L fusion events up to 120 min
(Fig. 5). Opsonized zymosan particles were found fused in
phagolysosomes with varying degrees of degradation. In
coinfections, ManLAM bead phagosomes without lysosomal
fusion were found in cells that also contained opsonized zy-
mosan particles in phagolysosomes (Fig. 5 A). The overall
levels of P-L fusion were not changed significantly for parti-
cles when used alone versus in combination (opsonized zy-
mosan, 80.7 
 
 
 
 11.5% vs. 78.1 
 
 
 
 6.7%; ManLAM beads,
24.1 
 
 
 
 0.1% vs. 15.5 
 
 
 
 5.1%; P value not significant) (Fig. 5
B). For these experiments, we used ManLAM beads of dif-
ferent sizes, both smaller and larger than the 5- to 8-
 
 
 
m-
sized opsonized zymosan particles. Equivalent results were
produced in all cases. Thus, the decrease in P-L fusion is spe-
cific to the ManLAM bead phagosome.
 
The macrophage MR plays an important role in regulating 
P-L fusion of ManLAM beads
Specific phagocyte receptors direct the trafficking of
newly formed phagosomes following phagocytosis (11).
Because the MR is the principal receptor on human mac-
rophages for ManLAM (27), we investigated whether the
MR plays a role in limiting the degree of P-L fusion for
ManLAM beads by using several complementary ap-
proaches. First, we performed a P-L fusion assay using
human monocytes, which do not express functional MR
(28), and consequently phagocytose less ManLAM beads
comparable to control beads (27). The degree of P-L fu-
sion for phagosomes containing HSA or ManLAM beads
was equivalent in monocytes (33.6   2.8% vs. 32.4  
2.1%, respectively; n   2). In the second approach, HSA
or ManLAM beads were added to MDMs in the presence
or absence of mannan, a competitive blocker of the MR
(14). Mannan did not influence the degree of P-L fusion
for HSA beads (Fig. 6 A). In contrast, the low level of P-L
fusion seen with ManLAM beads (10.5   0.3%) was re-
versed with mannan (29.8   2.4%; n   2, P   0.005) to
a level comparable to HSA beads (31.9   2.8%).
As a complementary third approach, we preincubated
MDM monolayers with anti-MR mAb to block MR activity
more specifically before adding ManLAM beads for the P-L
fusion assay (Fig. 6 B). Both IgG1 mAb preincubated mono-
layers and HSA beads were used as controls. P-L fusion of
Figure 5. Limited P-L fusion is restricted to the ManLAM bead 
phagosome. MDM monolayers were incubated with ManLAM beads 
(20  m) for 1 h followed by the addition of opsonized zymosan for 1 h 
before fixation. P-L fusion was analyzed by TEM as in Fig. 1. (A) Electron 
micrograph ( 10,000) shows one unfused ManLAM bead phagosome 
along with an opsonized zymosan particle in a phagolysosome (arrow). 
A second ManLAM miscrosphere (shown at the bottom surface of the 
cell) is forming a phagocytic cup on the cell membrane. (B) The bar 
graph shows that the levels of P-L fusion for either opsonized zymosan 
or ManLAM beads phagocytosed individually by MDMs do not change 
when both types of particles are phagocytosed by the same cell. Shown 
is a representative experiment (n   3).MR-MANLAM–MEDIATED PHAGOSOME–LYSOSOME FUSION | Kang et al. 992
HSA beads added to macrophages pretreated with IgG1 or
anti-MR mAb was 44.7   1.35% and 48.3   1.7%, respec-
tively. ManLAM beads incubated with macrophages pre-
treated with IgG1 demonstrated limited P-L fusion (18.5  
0.2%; n   2, P   0.001 when compared with the HSA bead
groups). In contrast, when ManLAM beads were added to
macrophages pretreated with anti-MR mAb, the limited degree
of P-L fusion reversed completely to control levels (46.6  
2.6%) (Fig. 6 B). As expected, the total number of ManLAM
beads associated with anti-MR mAb-treated macrophages
was less than with the control IgG1-treated macrophages.
In the fourth approach, we precoated ManLAM beads
with the anti-LAM mAbs CS-35 or CS-40 (29, 30) (or pre-
incubated them with IgG subtype control) to both mask the
mannose caps and also redirect phagocytosis via Fc  recep-
tors that promote P-L fusion. ManLAM beads treated with
CS-35 or CS-40 demonstrated high degrees of P-L fusion
(70.0   3.5% and 74.6   0.4%, respectively) as opposed to
the level of P-L fusion for ManLAM beads preincubated
with no Ab or IgG subtype control (26.6   4.5% and 33.4  
0.5%, respectively; n   2, P   0.0005 relative to the CS-35
and CS-40 groups) (Fig. 6 C).
The above experiments with macrophages provided evi-
dence that engagement of the MR is necessary to limit P-L
fusion of ManLAM beads following phagocytosis. We next
examined whether the MR is sufficient in limiting P-L fusion
Figure 6. MR blockade with mannan or anti-MR antibody and 
redirected entry via Fc Rs reverse the inhibition of P-L fusion of 
ManLAM beads in macrophages to control levels. (A) MDMs were 
preincubated with or without mannan for 30 min before adding HSA or 
ManLAM beads and allowing for synchronized phagocytosis over 60 min. 
P-L fusion was examined and enumerated by TEM as in Fig. 1 F (mean   
SEM, n   2) and was significantly reduced with untreated ManLAM beads 
compared with the HSA control and mannan-treated bead groups (P   0.005, 
one-way ANOVA). (B) MDMs were preincubated with anti-MR or control 
IgG1 mAbs (10  g/ml) for 20 min at 37 C followed by the addition of either 
HSA or ManLAM beads (MOI 100–200:1), and phagocytosis assay was then 
performed for 2 h. The cells were fixed, permeabilized, blocked, and then 
stained with anti-CD63 mAb followed by Alexa Fluor 647-conjugated mouse 
IgG. P-L fusion was examined and enumerated by confocal microscopy 
(mean   SEM, n   2). Data were analyzed via one-way ANOVA comparing 
the value of the ManLAM bead group (IgG1 mAb-treated MDMs) with 
those of the HSA bead control groups and the ManLAM bead group (MR 
mAb-treated MDMs) (P   0.001). Inset: A control IgG1 mAb-treated MDM 
shows limited P-L fusion (left panel) and an anti-MR mAb-treated MDM 
shows increased P-L fusion (right panel) of ManLAM bead phagosomes. 
CD63-positive compartments are red, beads in unfused phagosomes are 
green, and those colocalized with CD63 are yellow. (C) ManLAM beads 
were preincubated with anti-LAM mAbs CS-35 or CS-40, IgG subtype control, 
or no mAb at 37 C for 60 min, washed, and added to MDM monolayers for 
the synchronized phagocytosis assay (60 min). P-L fusion was examined 
and quantified via TEM as in Fig. 1 F (mean   SEM, n  2) and was signifi-
cantly increased in the groups treated with either CS-35 or CS-40 compared 
with each control group (P   0.0005, one-way ANOVA).JEM VOL. 202, October 3, 2005 993
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by using a stable transfectant of the COS-1 cell expressing
full-length MR (COS1-MR). This nonphagocytic fibroblast
cell line has been used successfully as a model for phagocyto-
sis of yeast cells mediated by the human macrophage MR
(31) and for examining postphagocytic trafficking events of
zymosan particles mediated by Fc RIIA (32). COS1-WT or
COS1-MR monolayers were incubated with ManLAM
beads in synchronized phagocytosis and P-L fusion assays.
Cells were stained with the endosomal–lysosomal marker
CD63 or LAMP-2 and analyzed for P-L fusion via confocal
microscopy (Fig. 7). The total number of beads associated
with COS1-WT and COS1-MR was 720   26 and 1,424  
39 per 50 cells in each case, respectively (n   2). However,
results showed a higher level of P-L fusion for ManLAM
beads in COS1-WT cells (mean % P-L fusion at a multiplic-
ity of infection [MOI] of 100:1   13.3   1.6%, n   2, using
CD63 or LAMP-2 antibodies) than in COS1-MR cells
(mean % P-L fusion at an MOI of 100:1   6.0   0.4%, n  
2, using CD63 or LAMP-2 antibodies) (Fig. 7, A and B).
This represented a 55   4% reduction in P-L fusion using the
COS1-MR cells. As additional controls, we used HSA beads
with COS1-WT and COS1-MR, which showed 12.1  
0.9% and 10.4   1.1% P-L fusion (n  2), respectively, under
the same conditions. The reduction in P-L fusion was consis-
tent in assays using ManLAM beads at two different MOIs
(100:1 and 20:1) and both CD63 and LAMP-2 mAbs (Fig. 7
B). Thus expression of the MR in a heterologous cell line
caused a reduction in P-L fusion of ManLAM beads.
In a separate set of experiments, we analyzed the degree
of P-L fusion for ManLAM beads mediated by the C-type
lectin, DC-SIGN, using DC-SIGN-expressing COS-1 cells.
The total number of beads associated with COS1-WT,
COS1-MR, and COS1-DC-SIGN in this set of experiments
was 512   20, 1,102   35, and 1,150   24 per 50 cells in
each case, respectively (n   2). We found a comparable level
of P-L fusion for ManLAM beads between COS1-WT and
COS1-DC-SIGN cells (11.5   2.8% vs. 9.5   2.2% mean %
P-L fusion at an MOI of 100:1 using CD63 or LAMP-2 anti-
bodies; n   2), as opposed to the low level of P-L fusion with
COS1-MR cells (3.2   0.5% using CD63 or LAMP-2 anti-
bodies; n   2), indicating that, unlike the MR, entry via
DC-SIGN is not associated with reduced P-L fusion.
Figure 7. ManLAM beads demonstrate reduced P-L fusion in 
MR-expressing COS-1 cells. COS1-WT and COS1-MR cells adhered to 
glass coverslips were incubated with ManLAM beads (MOI 20:1 or
100:1) for 3 h using a synchronized phagocytosis assay. Cell monolay-
ers were fixed, permeabilized, and stained with anti–human CD63 or 
LAMP-2 mAbs followed by Alexa Fluor 647-conjugated goat anti–mouse 
IgG. P-L fusion was examined and enumerated via confocal microscopy. 
(A) Phase and fluorescence microscopy images of ManLAM beads in 
COS1-WT and COS1-MR cells. CD63 positive compartments are red, 
beads in unfused phagosomes are green, and those colocalized with 
CD63 are yellow. Shown is a representative experiment (n   2). DIC, 
differential interference contrast; IF, immunofluorescence. (B) Percent 
P-L fusion of ManLAM beads using two different MOIs (100:1 and 20:1, 
n   2, performed in duplicate).MR-MANLAM–MEDIATED PHAGOSOME–LYSOSOME FUSION | Kang et al. 994
As a final approach, we evaluated the degree of P-L fu-
sion in human macrophages for phagosomes containing live
M.tb strains Erdman or H37Ra in the presence or absence of
mannan during phagocytosis (Fig. 8). As previously shown,
phagocytosis of M.tb Erdman is mediated by the MR and
complement receptors, and phagocytosis of M.tb H37Ra oc-
curs primarily via complement receptors (14). Our results
showed that for phagosomes containing live M.tb Erdman,
the degree of P-L fusion with or without mannan was 84.0  
5.1% and 38.6   0.6%, respectively, whereas for phago-
somes containing M.tb H37Ra the degree of P-L fusion with
or without mannan was 88.3   5.8% and 62.7   4.4%, re-
spectively (Fig. 8). Thus, similar to the results with Man-
LAM beads, blockade of the MR during phagocytosis of
M.tb led to a reversal of the limited P-L fusion normally
seen. The basal level of P-L fusion for the attenuated H37Ra
strain was higher than that seen with the virulent Erdman
strain; however, in both cases an increase in P-L fusion was
observed with MR blockade.
Heat-killed and  -irradiated M.tb have markedly altered cell 
wall morphology and reduced amounts of ManLAM 
on the surface
In contrast with live mycobacteria, the phagosome of heat-
killed M.tb fuses at a higher rate with lysosomes (33, 34). Be-
cause ManLAM is a lipoglycan, it is presumed to be resistant
to heating, and heat-killed mycobacteria could be predicted
to have unaltered ManLAM on their surface. However, no
data exist on the nature of the cell wall of heat-killed myco-
bacteria. The process of killing M.tb at 80–90 C is harsh,
with the potential to markedly alter the cell wall and release
or modify ManLAM on its cell surface. To examine this pos-
sibility, we used immunogold TEM with the anti-LAM
mAbs CS-35 and CS-40 to localize ManLAM on the M.tb
cell surface (Fig. 9). A significant number of live M.tb that
were directly fixed in paraformaldehyde demonstrated an in-
tact cell wall architecture with intense staining for ManLAM
(Fig. 9, A, B, D, and E). In contrast, only  25% of heat-
killed bacilli demonstrated an intact cell wall architecture
(relative to live M.tb) and these bacilli had significantly less
ManLAM on their surface (Fig. 9, C–E). Further, our studies
revealed that  -irradiated M.tb are essentially devoid of an in-
tact cell wall architecture and more distorted than heat-killed
bacilli, and have little ManLAM on their surface (Fig. 9, D
and E). These studies make the important observation that
heat-killing and  -irradiation are very destructive procedures
for the mycobacterial cell wall structure and lead to Man-
LAM being released. The loss of ManLAM likely limits the
ability of bacilli to interact with the MR during phagocytosis.
DISCUSSION
Macrophage PRRs recognize a variety of microbial surface
determinants and bridge innate and adaptive immune re-
sponses by regulating endosomal and phagosomal traffic as
well as pro- and anti-inflammatory cytokine production. Al-
though much attention has recently focused on the ability of
M.tb ManLAM to regulate phagosome biogenesis, the role of
specific macrophage PRRs in directing this process has not
been clear. Here we provide several lines of evidence to dem-
onstrate that engagement of the MR by M.tb ManLAM di-
rects phagocytic particles and live M.tb bacilli to a phagosomal
compartment that has limited fusion with lysosomes. This
process is specific for the MR and ManLAM, because entry of
ManLAM via another C-type lectin PRR, DC-SIGN, does
not mediate this effect, nor does PILAM or LM. Also, mono-
cytes that do not express the MR are not capable of limiting
P-L fusion. Furthermore, limited P-L fusion can be reversed
by masking the mannose caps of ManLAM and redirecting
ManLAM entry through other phagocytic receptors such as
Fc Rs. The MR is sufficient in limiting P-L fusion as evi-
denced by experiments using COS1-MR cells where the re-
duction in P-L fusion ( 50%) was comparable to that seen
with human macrophages. Such an event was specific to the
ManLAM-containing phagosome rather than due to a global
effect of ManLAM on vesicle trafficking in the cell. Most
compelling, our data provide the first evidence that MR
blockade on human macrophages results in increased P-L fu-
sion of live M.tb following phagocytosis (Fig. 8).
This work lends support to a two-step model for M.tb
phagosome biogenesis. In step 1, recognition of M.tb surface
determinants by specific receptors leads to receptor-medi-
ated signaling, actin cytoskeleton reorganization, and di-
rected entry into the nascent phagosome. Evidence for such
a step comes from numerous studies demonstrating the ra-
pidity with which microbial engulfment occurs, the phago-
Figure 8. MR blockade increases the level of P-L fusion of phago-
somes containing live M.tb bacilli following phagocytosis. MDMs 
were preincubated with or without mannan at 37 C for 30 min followed 
by incubation with the live M.tb strains Erdman and H37Ra (MOI of 6.25 
bacilli per MDM) for 2 h. P-L fusion was examined and quantified via TEM 
as in Figure 1 F (mean   SEM, n   2). **P   0.01 (Erdman) and *P   0.05 
(H37Ra) relative to the no mannan condition for each strain.JEM VOL. 202, October 3, 2005 995
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some is generated and fusion and fission events within the
endolysosomal pathway proceed ( 30 min) (11). That lim-
ited P-L fusion can be reversed by redirecting ManLAM and
M.tb bacilli to alternative phagocytic pathways emphasizes
the importance of this step. In step 2, the unique M.tb
phagosome is maintained over hours to days. Here M.tb via-
bility is particularly critical, and several bacterial-derived
processes are active in blocking phagosome maturation (6).
Recent studies provide convincing evidence that Man-
LAM blocks phagosome maturation in murine macrophages
and a human monocytic cell line (9, 10). Our present study is
consistent with these observations and extends them to primary
human macrophages. We demonstrate for the first time the
importance of the MR in this process with both ManLAM and
live virulent M.tb. The published work using the murine mac-
rophage cell line J774 (10) did not examine the contribution of
the MR, reported to be expressed by these cells (35).
The MR is a type I transmembrane glycoprotein and
member of the C-type lectin family that binds mannose and
fucose with highest affinity (36). Detailed studies on traffick-
ing of the MR have focused primarily on pinocytosis using
mannosylated proteins (37). Macrophages contain large intra-
cellular pools of MR within early endosomes, which undergo
continual rapid recycling to the cell surface (37). The intra-
cellular compartment containing macroparticles ( 1   m)
phagocytosed by the MR has not been well characterized.
Little is known regarding MR-specific signaling and traf-
ficking pathways. However, the literature provides clues to
the potential mechanisms whereby the MR may regulate
phagosomal traffic. MR expression/function is increased by
IL-4 and IL-13 (38–40) and is inhibited by IFN . IL-4 and
IL-13 decrease, whereas IFN  increases particle sorting to
lysosomes (39). Enhanced MR endocytic activity by IL-4
and IL-13 involves activation of phosphatidylinositol 3 kinases
(39) that are critically involved in cytoskeletal organization.
Thus these data suggest that the MR may preferentially sort
phagocytosed particles to nonlysosomal compartments. Rel-
evant to M.tb pathogenesis, IL-4 and IL-13 produce an alter-
native activation state of macrophages [reviewed in (41)] that
may enhance intracellular survival of microbes. Alveolar mac-
rophages are a prototypic alternatively activated cell with high
MR activity.
Our studies show that both the MR and DC-SIGN rec-
ognize ManLAM, but regulate phagosomal trafficking differ-
ently, where DC-SIGN directs phagocytic particles to the
phagolysosome. Several studies have reported that DC-SIGN
and its homologues L-SIGN and SIGNR1 target ManLAM
and/or mycobacteria to lysosomes in dendritic cells (17, 42,
43). This observation is supported by the fact that the cyto-
plasmic tail of DC-SIGN possesses the “tri-acidic cluster and
di-leucine” signaling motifs that target endocytosed molecules
to lysosomes and MHC class II–positive late endosomes (44).
Figure 9. Heat-killing and  -irradiation of M.tb alter the integrity 
of the bacterial cell wall and decrease the amount of surface-exposed 
ManLAM. Single suspensions of plate-grown M.tb strain Erdman were kept 
alive or were killed by heating or  -irradiation. Bacilli were fixed with 2% 
paraformaldehyde, washed, embedded in LR White, thin sectioned, and 
immunostained with anti-LAM mAb CS-35 or CS-40 followed by 10 nm 
immunogold-conjugated goat anti–mouse secondary antibody before viewing 
by TEM. Electron micrographs of (A) live M.tb stained with CS-35 (bar, 
100 nm), (B) live M.tb stained with CS-40 (bar, 100 nm), or (C) heat-killed 
M.tb stained with CS-35 (bar, 100 nm). (D) Graph shows percentage of bacilli 
in the indicated groups that have an intact cell wall architecture. (E) Graph 
shows amount of ManLAM exposed on the surface of live, heat-killed, and 
 -irradiated M.tb. Results are shown as a percentage of immunogold 
particles/M.tb bacillus relative to control live M.tb set at 100% (*P   0.05).MR-MANLAM–MEDIATED PHAGOSOME–LYSOSOME FUSION | Kang et al. 996
The MR lacks such motifs and has only one immunore-
ceptor tyrosin-based activation motif–like cytoplasmic motif
containing Tyr18 (a member of a diaromatic amino acid se-
quence), which is involved in efficient phagocytosis and en-
docytosis (45, 46) and endosomal sorting (46). Thus these
studies, along with the data in the current work, raise the
possibility that the trafficking fate of M.tb bacilli and Man-
LAM in a given cell following phagocytosis will depend on
the relative amount and activity of the MR and DC-SIGN
on the cell surface. Because macrophages express high MR
and DCs express high DC-SIGN activities, we speculate that
this difference may provide one explanation for why mac-
rophages serve as the major intracellular niche for M.tb
rather than DCs, which are more potent in processing en-
docytosed products in lysosomes. Published literature and
our own unpublished data provide evidence for little or no
DC-SIGN expression on MDMs (47).
Beyond these observations, ligation of the MR by Man-
LAM has been linked to the generation of an anti-inflamma-
tory cytokine program on monocyte-derived DCs (19, 21)
and, in one study, to calcium responses in MDMs (48). The
latter is of interest given that maturation arrest of the M.tb
phagosome has been linked to a block in the increase of cyto-
solic calcium during phagocytosis of live virulent M.tb by hu-
man macrophages. This is due to a defect in signaling by
Ca2 /calmodulin-dependent protein kinase II and sphingo-
sine kinase (49, 50). Thus it is possible that ligation of the MR
by ManLAM generates a negative signal for P-L fusion events
in the host cell, a hypothesis we are currently exploring.
We have previously determined that the MR is involved
in phagocytosis of the virulent M.tb strains Erdman and
H37Rv but not the attenuated strain H37Ra by MDMs (14).
However, when ManLAMs purified from these strains were
studied for MR involvement in phagocytosis using the bead
model, we found that all three ManLAM types are recog-
nized by the MR, but to a different extent (Erd-ManLAM  
Rv-ManLAM   Ra-ManLAM) (51). In the current study,
all three purified ManLAMs limited P-L fusion to a similar
extent. However, a different picture emerged when live ba-
cilli were used. The high degree of P-L fusion observed in
the presence of mannan for the M.tb H37Ra strain was similar
to that of the M.tb Erdman strain; however, the basal level of
P-L fusion in the absence of mannan was significantly higher
for the M.tb H37Ra strain (Fig. 8), as was observed in an early
study (52). Taken together, our data suggest that there is only
a very small interaction of the live M.tb H37Ra strain with the
MR during phagocytosis by MDMs that is difficult to detect
in tissue culture and that this limited interaction results in a
higher degree of P-L fusion during phagocytosis. There is
accumulating evidence that the precise nature of the man-
nose caps of ManLAM and their presentation may impact
recognition by the MR and consequently the host response.
Our study provides new insight into the structural do-
mains of ManLAM that are important in the limiting of P-L
fusion. It is clear that the mannose caps of ManLAM play a
key role in this process by binding to the carbohydrate rec-
ognition domains of the MR. We hypothesize that the
branching arabinofurans of ManLAM play an important role
in properly orienting the mannose caps for recognition by
the MR. LM limited P-L fusion poorly (Fig. 4), consistent
with its inability to bind to the MR (15), which is likely due
to the nature of its mannan linkages (53) in the presence of
the lipid tail. Our data provide evidence that both the glyco-
syl phosphatidyl-1-myo-inositol anchor and carbohydrates of
ManLAM are important in limiting P-L fusion over time,
because the limited P-L fusion seen with mannan, arabi-
nomannan, and dManLAM was reversed between 2 and 6 h.
The ability of the glycosyl phosphatidyl-1-myo-inositol an-
chor to intercalate into the plasma membrane of mammalian
cells (54) may be important in limiting P-L fusion over time.
Our studies on heat-killed and  -irradiated M.tb provide
evidence that the surface-exposed molecules of these bacilli
are globally altered and as such would be expected to inter-
act with the macrophage very differently from live mycobac-
teria. This concept is supported by a recent study that de-
scribed a difference between live and dead bacilli with regard
to P-L fusion related to a heat-sensitive secreted M.tb lipid
phosphatase (34). These data, together with our finding that
live bacilli retain greater amounts of ManLAM on their sur-
face than killed bacilli, highlight the importance of an intact
mycobacterial cell wall architecture in early microbe–host
interactions. The presence of ManLAM on the surface of
live bacilli enhances their interaction with the MR and MR-
mediated trafficking pathways.
Relevance of the MR to tuberculosis is highlighted by
recent human genetic studies that show a major locus for
susceptibility to mycobacterial infection on chromosome
10p13, mapped to the location of the MR gene (55, 56).
Our accumulated data from this and previous studies strongly
support the notion that the MR-ManLAM pathway initiates
the development of a safe intracellular niche for M.tb follow-
ing phagocytosis and thus plays an important role in the
pathogenesis of tuberculosis.
In this study, we add an important missing piece to the
growing body of evidence that ManLAM regulates M.tb
phagosome biogenesis. We demonstrate that engagement of
the MR on human macrophages by M.tb ManLAM initiates
a specific phagocytic pathway that results in limited P-L fu-
sion. Because the alveolar macrophage has relatively high
MR activity, we reason that use of the MR-ManLAM path-
way may be particularly important in the outcome of pri-
mary infection in the lung, where the number of M.tb bacilli
encountering this cell is believed to be very low.
MATERIALS AND METHODS
Antigens and antibodies. Rv-ManLAM, dManLAM, M.tb LM, PILAM
from M. smegmatis, and CS-35 and CS-40 mAbs were provided by John T.
Belisle (Colorado State University, Fort Collins, CO; NIH-NIAID contract
NO1 AI-75320). Erd-ManLAM and Ra-ManLAM were purified as de-
scribed previously (51). For experiments with COS-1 cells, Rv-ManLAM
from plate-grown M.tb H 37Rv was purified as described previously (57).
M.tb H37Rv arabinomannan and mannan were kindly provided by Mama-
dow Daffe (Institut de Pharmacologie et Biologie Structurale, Toulouse,JEM VOL. 202, October 3, 2005 997
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France) (58). Anti–human LAMP-1 (H4A3) and LAMP-2 (H4B4) mAbs
were purchased from the University of Iowa Hybridoma Bank. Anti–
human CD63 (for immunofluorescence) and CD206 (for flow cytometry)
mAbs were purchased from BD Biosciences. For receptor blocking, CD206
(MR) mAb was purchased from Serotech. Ultra-small immunogold conju-
gate antibody was obtained from AURION and labeled goat anti–mouse
IgG was obtained from Invitrogen.
Monocyte-derived macrophages. PBMCs  were isolated from healthy
donors (using an approved protocol by The Ohio State University Institu-
tional Review Board) and day 1 monocytes or day 5 MDMs cultivated as
described previously (27). Monolayers in 24-well tissue culture plates con-
tained approximately 1.5–2.0   105 monocytes or MDMs.
Preparation of M.tb cell suspensions and washed, HSA-coated, and
lipoglycan-coated polystyrene beads. Single suspensions of M.tb for
P-L fusion assays were prepared using 9–12 d plate-grown bacilli as de-
scribed (14). HSA- (sham control), ManLAM-, PILAM-, LM-, dManLAM-,
mannan-, and arabinomannan-coated beads were prepared as previously de-
scribed previously (15) using Polybead polystyrene beads (1, 6, or 20  m in
diameter) (Polysciences). Beads were finally adjusted to 4.0   108/ml in
0.5% HSA before use with MDMs or COS-1 cells. For washed beads, Poly-
bead polystyrene beads were washed twice in 0.05 M carbonate-bicarbon-
ate buffer before use.
Synchronized phagocytosis assay. Monocyte or MDM monolayers on
coverslips were briefly (2 min) cooled to 4 C before adding the beads (4  
107/well) at 4 C for 5 min to allow them to settle onto the surface of the
monolayers; monolayers were subsequently warmed up to 37 C for various
periods. For TEM assays of P-L fusion, monocyte or MDM monolayers
were incubated with 1 mg/ml horseradish peroxidase (Sigma-Aldrich) in
RPMI 1640-20 mM Hepes containing 1 mg/ml HSA (RHH medium) at
37 C for 2 h, washed and chased for 1 h in RHH medium before adding
the beads (59).
Quantitative P-L fusion assay using TEM. After the synchronized
phagocytosis assay using beads, cell monolayers were washed with pre-
warmed RPMI 1640 medium, fixed in 2.5% glutaraldehyde in 0.1 M so-
dium cacodylate buffer (pH 7.2) for 60 min, and washed three times in so-
dium cacodylate buffer. To reveal peroxidase, monolayers were then
incubated at RT for 15 min in 0.05 M Tris-HCl buffer (pH 7.6) containing
1 mg/ml diaminobenzidine and 0.01% H2O2 followed by postfixation in
1% osmium tetroxide and an en bloc staining in 2.5% uranyl acetate. After
dehydration in gradient ethanol solutions (15 min each in 50 and 70% etha-
nol, 30 min in 95%, and 60 min in 100% ethanol with 2 changes), mono-
layers were embedded in the mixture of Eponate 12 and ethanol (1:1) O/N.
Two further incubations in 100% Eponate were performed before curing
the samples at 70 C O/N. Thin sections were then cut at 100 nm and
stained with 5% uranyl acetate and Reynold’s lead citrate before viewing by
TEM. For the P-L fusion assay using live M.tb, bacilli (1.25   106/well)
were incubated with horseradish peroxidase–preloaded MDM monolayers
at 37 C for 2 h, washed, sections prepared for TEM, and P-L fusion for sin-
gle bacteria within phagosomes was quantified.
In certain TEM experiments, MDM monolayers were preincubated
with or without mannan (4 mg/ml) at 37 C for 30 min before adding beads
or live M.tb to the monolayers. In other experiments, beads were incubated
with anti-LAM mAbs CS-35 or CS-40 or subtype control mAb (1:300 di-
lution each) at 37 C for 60 min and washed before addition to the MDM
monolayers. Finally, in TEM experiments that used opsonized zymosan,
particles were incubated in 50% human serum and washed. Opsonized zy-
mosan particles were then added either alone or following a 60-min incuba-
tion with either HSA or ManLAM beads (1, 6, 10, or 20  m in diameter)
to MDM monolayers for an additional 60 min before fixation.
The percentage of bead, M.tb, or zymosan phagosomes that were fused
with lysosomes in the horseradish peroxidase assay was quantified by count-
ing  300 consecutive phagosomes in each test group in two independent
experiments using two different donors.
For the TEM immunohistochemical assay, MDM monolayers were
embedded in LR White and sections stained with a primary mAb against
LAMP-1, and then an ultra-small ( 1 nm) immunogold-conjugated goat
anti–mouse antibody followed by silver enhancement. The number of im-
munogold particles was quantified by counting over 1,000 consecutive
phagosomes in each test group in two independent experiments using two
different donors.
Quantitative P-L fusion assay using confocal microscopy. Phago-
cytosis assays with beads were performed as above, except that green fluores-
cent beads (1  m diameter; Polysciences) were used. Cell monolayers on
coverslips were washed with PBS, fixed with 2% paraformaldehyde, and per-
meabilized with 100% methanol for 5 min at RT. The cells were blocked
O/N at 4 C in blocking buffer (D-PBS   5 mg/ml BSA   10% heat-inac-
tivated fetal bovine serum), stained with mAbs against late endosomal/lyso-
somal markers (LAMP-1, LAMP-2, or CD63; 0.5  g/ml final concentration
for each), and next stained with Alexa Fluor 647-conjugated goat anti–
mouse IgG secondary antibody (4  g/ml final concentration). After exten-
sive washing in blocking buffer, the coverslips were dried, mounted on glass
slides, and examined via confocal microscopy (LSM 510; Carl Zeiss Micro-
Imaging, Inc.). In certain experiments, MDM monolayers were incubated
with isotype control IgG1 or anti-MR mAb at 37 C for 20 min before add-
ing HSA or ManLAM green fluorescent beads to the monolayers for 2 h.
The percentage of bead phagosomes that colocalized with lysosomal
markers was quantified by counting over 300 consecutive phagosomes in
each test group in two or more independent experiments using a minimum
of two different donors.
Creation of MR and DC-SIGN expression constructs and stable
COS-1 cell lines. A 4817-bp cDNA, spanning the full-length MR-
coding sequence and flanking regions, was obtained from IL-4 stimulated
human MDM MRNA via reverse-transcriptase polymerase chain reac-
tion using oligo-dT, M-MLV reverse transcriptase (Invitrogen), and se-
quence-specific primers. Initially, the fragment was cloned into pT7Blue
vector (Novagen). To create an MR expression construct, a 4490-bp
cDNA (MR sequence position 101–4591) (60) was amplified via poly-
merase chain reaction from the pT7Blue/MRcDNA clone by using
pfuUltra High Fidelity DNA Polymerase (Stratagene) and MR-specific
sense (5 -CACCGCCATGAGGCTACCCCTGCTCCTG-3 ) and anti-
sense (5 GGACAGACCAGTACAATTCAGTACTCA-3 ) primers.
The fragment was cloned into the mammalian expression vector
pcDNA3.1/V5-His-TOPO using a pcDNA3.1 Directional TOPO Ex-
pression Kit (Invitrogen) according to the manufacturer’s instructions.
The MR expression construct, designated pcDNA3.1/V5-His-TOPO/
4490-bp MR, was initially made in Escherichia coli TOP10 (supplied in
the kit) but was finally propagated and stabilized at 30 C in a special-pur-
pose E. coli Stbl2 strain (Invitrogen).
To make a DC-SIGN expression construct, a 1280-bp cDNA fragment
was amplified via polymerase chain reaction from Human Placenta
QUICK-Clone cDNA mix (BD Biosciences Clontech) using DC-SIGN–
specific sense (5 -CGCGGATCCAGAGTGGGGTGACATGAGTGAC-
3 ) and antisense (5 -CGGAATTCAGGTCGAAGGATGGAGAGAAGG-
3 ) primers. The fragment was cloned into the unique BamHI and EcoRI
sites (also added to the DC-SIGN primers, shown as underlined) of the
mammalian expression vector pSecTag2 (Invitrogen) resulting in the DC-
SIGN expression construct pSecTag2/DC-SIGN.
For construction of stable MR and DC-SIGN–expressing cell lines,
plasmid DNA of the individual constructs was transfected into COS-1 cells
(ATCC) using Lipofectamine 2000 Reagent (Invitrogen), according to the
supplier’s instructions. Transfected cells were initially selected in bulk with
the antibiotic G418 for MR and zeocin for DC-SIGN clones (400  g/ml
in each case). The antibiotic-resistant clones of each type were pooled to-
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R&D Systems) mAbs, and then subjected to sorting of positive cells into
single clones in a 96-well format via fluorescent-activated cell sorting
(FACSCalibur; Becton Dickinson). The single clones were further ex-
panded and screened for stable expression of the MR or DC-SIGN via flow
cytometry and Western blotting.
P-L fusion assay using COS-1 stable transfectants and ManLAM-
coated fluorescent beads. Freshly grown COS1-WT, COS1-MR, or
COS1-DC-SIGN cells were seeded onto coverslips (105 cells/well, tripli-
cate wells/test group) in wells of a 24-well tissue culture plate and incubated
O/N to form monolayers. Cell monolayers were washed and repleted with
PBS-HHG medium (PBS   10 mM Hepes   1 mg/ml HSA   0.1% glu-
cose) to which HSA or ManLAM beads were added (MOIs of 20–100:1)
followed by centrifugation of the culture plates at 4 C to pellet the beads
onto the monolayers. The cells were further cooled at 4 C for 15 min be-
fore warming up to 37 C for 3 h to allow for the synchronized uptake of
beads. After washing, the cells were fixed, permeabilized, stained with ei-
ther CD63 or LAMP-2 mAb and then Alexa Fluor 647-conjugated second-
ary antibody. The monolayers were processed for confocal microscopy and
analyzed as described above. The percentage of bead phagosomes that were
colocalized with the late endosome/lysosome markers was enumerated by
viewing 20 consecutive images (containing 1–5 cells/image) and counting
at least 500 beads in each test group for each of the two mAbs, CD63 or
LAMP-2, in two independent experiments.
TEM of live, heat-killed, and  -irradiated M.tb. Single suspensions
of plate-grown live M.tb strain Erdman were fixed in 2% paraformaldehyde
and processed for TEM. The morphology of the bacterial surface and pres-
ence of ManLAM were compared with groups in which the bacteria were
either heat-killed (at 80 C for 60 min) or  -irradiated (2.5 MRad for 18 h)
before fixation. Fixed bacteria were rinsed three times in cacodylate buffer
and postfixed with 1% osmium tetroxide in 0.1 M cacodylate buffer with
1.5% potassium ferrocyanide for 1.5 h. After rinsing with buffer and distilled
water, cells were stained with 2.5% uranyl acetate for 30 min. A stepwise
prolonged dehydration procedure was followed that consisted of 50% ace-
tone for 15 min, 70% acetone two times for 20 min each, 95% acetone
three times for 20 min each, and absolute acetone four times for 1 h each. A
1:1 mixture of absolute acetone and propylene oxide for 1 h was then fol-
lowed by two incubations in 100% propylene, the first for 45 min and the
second for O/N. The samples were embedded in an increasing concentra-
tion of Spurr’s resin (Polysciences) mixed with propylene oxide for 2 h.
Two O/N incubations in 100% Spurr’s resin were then performed before
curing at 60 C for 48 h. Thin sections were cut at 100 nm, stained with ei-
ther CS-35 or CS-40 anti-LAM mAb (1:10 dilution for each) followed by
secondary goat anti–mouse 10 nm conjugate antibody, and viewed by TEM
(Hitachi H-7000). The number of immunogold particles/M.tb bacillus was
enumerated for 50 or more bacteria in each group.
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